Target Name: ARR3
NCBI ID: G407
Review Report on ARR3 Target / Biomarker Content of Review Report on ARR3 Target / Biomarker
ARR3
Other Name(s): CArr | arrestin 4 | arrestin 3 retinal (X-arrestin) | Arrestin-C | ARRC_HUMAN | retinal cone arrestin-3 | MYP26 | Arrestin 4 | CAR | arrestin 3 | Cone arrestin | Retinal cone arrestin-3 | C-arrestin | X-arrestin | Arrestin 3 | cArr | ARRX

ARR3: A Protein Involved in Disease and Cancer Development

ARR3 (Alkylator-Recycling Regeneration System, ARR3) is a protein that is expressed in various tissues throughout the body, including the brain, lungs, heart, kidneys, and intestines. It is a key regulator of cellular recycling and is involved in the process of protein degradation and turnover. ARR3 has also been shown to play a role in the development and progression of various diseases, including cancer. As a result, ARR3 has become a focus of interest for researchers studying these conditions and for developing new treatments.

One of the key functions of ARR3 is its role in regulating protein degradation. In cells, proteins are constantly being broken down and replaced with new ones to ensure that cells are able to adapt to their environment and carry out their necessary functions. However, if proteins are not properly degraded, they can accumulate and interfere with the proper functioning of the cell. ARR3 helps to ensure that proteins are properly degraded by participating in the intracellular degradation pathway.

In addition to its role in protein degradation, ARR3 is also involved in the regulation of cellular recycling. Cells are constantly breaking down and recycling various types of molecules in order to maintain their structural integrity and function. ARR3 helps to ensure that these recycling processes are properly regulated by participating in the recycling pathway.

The role of ARR3 in disease development and progression is also being studied. Several studies have shown that ARR3 is involved in the development and progression of various diseases, including cancer. For example, ARR3 has been shown to be involved in the development of neurodegenerative diseases, such as Alzheimer's and Parkinson's diseases. Additionally, ARR3 has also been shown to play a role in the development of certain cancers, such as breast and colorectal cancers.

Based on these findings, ARR3 has become a focus of interest for researchers studying these diseases and for developing new treatments. Researchers are exploring new ways to target ARR3 in order to treat these conditions, including using small molecules, antibodies, and other therapeutic approaches. Additionally, researchers are also studying the potential benefits of ARR3 as a drug target, with the goal of developing new treatments for diseases that are currently treated with limited options.

In conclusion, ARR3 is a protein that plays a critical role in the regulation of cellular recycling and is involved in the development and progression of various diseases. As a result, ARR3 has become a focus of interest for researchers studying these conditions and for developing new treatments. Further research is needed to fully understand the role of ARR3 in disease and to develop new treatments based on its properties.

Protein Name: Arrestin 3

Functions: May play a role in an as yet undefined retina-specific signal transduction. Could bind to photoactivated-phosphorylated red/green opsins

The "ARR3 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about ARR3 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets

ARRB1 | ARRB2 | ARRDC1 | ARRDC1-AS1 | ARRDC2 | ARRDC3 | ARRDC3-AS1 | ARRDC4 | ARRDC5 | Arrestin | ARSA | ARSB | ARSD | ARSF | ARSG | ARSH | ARSI | ARSJ | ARSK | ARSL | ART1 | ART3 | ART4 | ART5 | ARTN | ARV1 | ARVCF | ARX | Arylsulfatase | AS3MT | ASAH1 | ASAH1-AS1 | ASAH2 | ASAH2B | ASAP1 | ASAP1-IT1 | ASAP1-IT2 | ASAP2 | ASAP3 | ASB1 | ASB10 | ASB11 | ASB12 | ASB13 | ASB14 | ASB15 | ASB16 | ASB16-AS1 | ASB17 | ASB18 | ASB2 | ASB3 | ASB4 | ASB5 | ASB6 | ASB7 | ASB8 | ASB9 | ASB9P1 | ASCC1 | ASCC2 | ASCC3 | ASCL1 | ASCL3 | ASCL4 | ASCL5 | ASF1A | ASF1B | ASGR1 | ASGR2 | ASH1L | ASH1L-AS1 | ASH2L | Asialoglycoprotein receptor | Asialoglycoprotein Receptor (ASGPR) | ASIC1 | ASIC2 | ASIC3 | ASIC4 | ASIC5 | ASIP | ASL | ASMER1 | ASMER2 | ASMT | ASMTL | ASMTL-AS1 | ASNS | ASNSD1 | ASNSP1 | ASPA | ASPDH | ASPG | ASPH | ASPHD1 | ASPHD2 | ASPM | ASPN | ASPRV1 | ASPSCR1